Department of Chemical Engineering, McGill University, 3610 University Street, Montreal, QC, H3A 2B2, Canada.
Ann Biomed Eng. 2011 Jan;39(1):402-13. doi: 10.1007/s10439-010-0145-9. Epub 2010 Aug 25.
Few studies have investigated whether fluid mechanics can impair or enhance endothelial cell response to pharmacological agents such as statin drugs. We evaluated and compared Kruppel-like factor 2 (KLF2), endothelial nitric oxide synthase (eNOS), and thrombomodulin (TM) expression in human abdominal aortic endothelial cells (HAAEC) treated with increasing simvastatin concentrations (0.1, 1 or 10 μM) under static culture and shear stress (steady, non-reversing pulsatile, and oscillating). Simvastatin, steady flow, and non-reversing pulsatile flow each separately upregulated KLF2, eNOS, and TM mRNA. At lower simvastatin concentrations (0.1 and 1 μM), the combination of statin and unidirectional steady or pulsatile flow produced an overall additive increase in mRNA levels. At higher simvastatin concentration (10 μM), a synergistic increase in eNOS and TM mRNA expression was observed. In contrast, oscillating flow impaired KLF2 and TM, but not eNOS expression by simvastatin at 1 μM. A higher simvastatin concentration of 10 μM overcame the inhibitory effect of oscillating flow. Our findings suggest that oscillating shear stress renders the endothelial cells less responsive to simvastatin than cells exposed to unidirectional steady or pulsatile flow. Consequently, the pleiotropic effects of statins in vivo may be less effective in endothelial cells exposed to atheroprone hemodynamics.
很少有研究探讨流体力学是否会损害或增强内皮细胞对他汀类药物等药理制剂的反应。我们评估并比较了在静态培养和切应力(稳态、非反转脉动和振荡)下,用不同浓度的辛伐他汀(0.1、1 或 10 μM)处理人腹主动脉内皮细胞(HAAEC)后,Kruppel 样因子 2(KLF2)、内皮型一氧化氮合酶(eNOS)和血栓调节蛋白(TM)的表达。辛伐他汀、稳态流和非反转脉动流各自分别上调了 KLF2、eNOS 和 TM 的 mRNA。在较低的辛伐他汀浓度(0.1 和 1 μM)下,他汀类药物和单向稳态或脉动流的组合产生了 mRNA 水平的总体相加增加。在较高的辛伐他汀浓度(10 μM)下,观察到 eNOS 和 TM 的协同增加。相比之下,振荡流在 1 μM 时抑制了 KLF2 和 TM 的表达,但对 eNOS 的表达没有影响。较高的辛伐他汀浓度(10 μM)克服了振荡流的抑制作用。我们的研究结果表明,振荡切应力使内皮细胞对辛伐他汀的反应性低于暴露于单向稳态或脉动流的细胞。因此,他汀类药物在体内的多效性作用可能在暴露于动脉粥样硬化倾向血流的内皮细胞中效果较差。